{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:08:35Z","timestamp":1789726115069,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,18]],"date-time":"2027-09-18T00:00:00Z","timestamp":1821225600000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ogla.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:56:28Z","timestamp":1772474188000},"page":"494-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Association between a Pharmacy-Based Estimate of Medication Adherence and Surgical and Laser Treatments in Patients with Glaucoma"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5273-2320","authenticated-orcid":false,"given":"Kenneth C.","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louay","family":"Almidani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7663-6759","authenticated-orcid":false,"given":"Chris","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-0782","authenticated-orcid":false,"given":"Jithin","family":"Yohannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ogla.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/1874364101711010305","article-title":"A single drop in the eye \u2013 effects on the whole body?","volume":"11","author":"Vaajanen","year":"2017","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.ogla.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/ACI.0b013e32834a95c9","article-title":"Ocular surface damage by ophthalmic compounds","volume":"11","author":"Mantelli","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ogla.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.mayocpiqo.2022.09.007","article-title":"Updates on the diagnosis and management of glaucoma","volume":"6","author":"Wagner","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.ogla.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IJG.0000000000001965","article-title":"Facilitators and barriers to glaucoma medication adherence","volume":"31","author":"Gatwood","year":"2022","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ogla.2026.02.005_bib6","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.ogla.2026.02.005_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jcm5090079","article-title":"Adherence to glaucoma medications over 12 months in two US community pharmacy chains","volume":"5","author":"Feehan","year":"2016","journal-title":"J Clin Med"},{"key":"10.1016\/j.ogla.2026.02.005_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","article-title":"The assessment of refill compliance using pharmacy records: methods, validity, and applications","volume":"50","author":"Steiner","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ogla.2026.02.005_bib9","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1167\/iovs.07-0290","article-title":"Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS)","volume":"48","author":"Friedman","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/PPA.S23780","article-title":"Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review","volume":"5","author":"Reardon","year":"2011","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ogla.2026.02.005_bib11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/IJG.0000000000001943","article-title":"Topical medication adherence and visual field progression in open-angle glaucoma: analysis of a large US health care System","volume":"30","author":"Shu","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ogla.2026.02.005_bib12","first-page":"808","article-title":"Predictors of nonadherence to topical intraocular pressure reduction medications among Medicare members: a claims-based retrospective cohort study","volume":"22","author":"Sheer","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.ogla.2026.02.005_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ogla.2025.10.003","article-title":"The effect of medication adherence on intraocular pressure and glaucoma progression","volume":"9","author":"Almidani","year":"2025","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2026.02.005_bib14","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1080\/03007995.2018.1477747","article-title":"A systematic literature review comparing methods for the measurement of patient persistence and adherence","volume":"34","author":"Forbes","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ogla.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","article-title":"The association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study (CIGTS)","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","article-title":"The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity","volume":"118","author":"Sleath","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.02.005_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5301\/EJO.2010.6112","article-title":"Do adherence rates and glaucomatous visual field progression correlate?","volume":"21","author":"Rossi","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.02.005_bib18","first-page":"45","article-title":"Determining adherence to inhaled corticosteroids from the epic electronic medical record","volume":"29","author":"Galbreath","year":"2024","journal-title":"J Pediatr Pharmacol Ther JPPT"},{"key":"10.1016\/j.ogla.2026.02.005_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026582","article-title":"Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta-analysis involving 27 million patients","volume":"11","author":"Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ogla.2026.02.005_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107931","article-title":"Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: a narrative review","volume":"35","author":"Denicol\u00f2","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ogla.2026.02.005_bib21","first-page":"25","article-title":"Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis","volume":"3","author":"H\u00f6er","year":"2009","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ogla.2026.02.005_bib22","doi-asserted-by":"crossref","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","article-title":"Primary open-angle glaucoma preferred practice pattern","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.02.005_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.02.005_bib24","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00417-013-2464-7","article-title":"Global rates of glaucoma surgery","volume":"251","author":"Mansouri","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ogla.2026.02.005_bib25","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ophtha.2017.04.035","article-title":"Evidence-based criteria for assessment of visual field reliability","volume":"124","author":"Yohannan","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.02.005_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ophtha.2019.08.027","article-title":"Evidence based criteria for determining peripapillary OCT reliability","volume":"127","author":"Yohannan","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.02.005_bib27","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1167\/iovs.15-17248","article-title":"Residual and dynamic range of retinal nerve fiber layer thickness in glaucoma: comparison of three OCT platforms","volume":"56","author":"Mwanza","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2026.02.005_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ajo.2010.06.024","article-title":"Comparison of retinal nerve fiber layer thickness in normal eyes using time-domain and spectral-domain optical coherence tomography","volume":"150","author":"Seibold","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.02.005_bib29","series-title":"Clinical Decisions in Glaucoma","author":"Hodapp","year":"1993"},{"issue":"7","key":"10.1016\/j.ogla.2026.02.005_bib30","first-page":"457","article-title":"Measuring concurrent adherence to multiple related medications","volume":"15","author":"Choudhry","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ogla.2026.02.005_bib31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/IJG.0000000000001943","article-title":"Topical medication adherence and visual field progression in open-angle glaucoma: analysis of a large US health care system","volume":"30","author":"Shu","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ogla.2026.02.005_bib32","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1111\/bcp.15391","article-title":"Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: a scoping review and new tool TEN-SPIDERS","volume":"88","author":"Dalli","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ogla.2026.02.005_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40545-021-00385-w","article-title":"Estimating proportion of days covered (PDC) using real-world online medicine suppliers' datasets","volume":"14","author":"Prieto-Merino","year":"2021","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.ogla.2026.02.005_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2003.12.009","article-title":"Determinants of eye drop size","volume":"49","author":"Van Santvliet","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ogla.2026.02.005_bib35","first-page":"732","article-title":"An objective evaluation of eyedrop instillation in patients with glaucoma","volume":"127","author":"Stone","year":"2009","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"10.1016\/j.ogla.2026.02.005_bib36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(14)74225-4","article-title":"Compliance with topical timolol treatment","volume":"103","author":"Kass","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.02.005_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/clpt.1989.121","article-title":"Time to stop counting the tablets?","volume":"46","author":"Pullar","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ogla.2026.02.005_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ophtha.2009.01.021","article-title":"Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma","volume":"116","author":"Friedman","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.02.005_bib39","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/03007995.2017.1321534","article-title":"Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications","volume":"33","author":"Malo","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ogla.2026.02.005_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2020.21899","article-title":"Glaucoma in adults-screening, diagnosis, and management: a review","volume":"325","author":"Stein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ogla.2026.02.005_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1472-6963-12-270","article-title":"Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss","volume":"12","author":"Meddings","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ogla.2026.02.005_bib42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1742-1241.2012.02918.x","article-title":"Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians' perceptions of adherence vs. pharmacy claims","volume":"66","author":"Stephenson","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ogla.2026.02.005_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.12.10.18","article-title":"Identifying, understanding, and addressing disparities in glaucoma care in the United States","volume":"12","author":"Davuluru","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ogla.2026.02.005_bib44","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2147\/OPTH.S514689","article-title":"The relationship of frailty with surgical and laser treatment for patients with glaucoma","volume":"19","author":"Groothoff","year":"2025","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"10.1016\/j.ogla.2026.02.005_bib45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41433-020-0806-3","article-title":"Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis","volume":"34","author":"Hashemi","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.ogla.2026.02.005_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/bjo.2010.196907","article-title":"Retinal nerve fibre layer and visual function loss in glaucoma: the tipping point","volume":"96","author":"Wollstein","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.02.005_bib47","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","article-title":"Patterns of glaucoma medication adherence over four years of Follow-Up","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.02.005_bib48","series-title":"StatPearls","article-title":"Cyclodiode laser glaucoma therapy","author":"Allbon","year":"2025"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419626000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419626000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:38:03Z","timestamp":1789724283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419626000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589419626000220"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2026.02.005","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association between a Pharmacy-Based Estimate of Medication Adherence and Surgical and Laser Treatments in Patients with Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}